![](/img/cover-not-exists.png)
17β-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer
Joanna M. Day, Paul A. Foster, Helena J. Tutill, Michael F.C. Parsons, Simon P. Newman, Surinder K. Chander, Gillian M. Allan, Harshani R. Lawrence, Nigel Vicker, Barry V.L. Potter, Michael J. Reed, AVolume:
122
Year:
2008
Language:
english
Pages:
10
DOI:
10.1002/ijc.23350
File:
PDF, 551 KB
english, 2008